ECS Botanics has initiated a direct-to-consumer business strategy to sell $380,000 worth of soft gel capsules and oils under the RAP brand. The company signed a one-year commercial agreement with Elite Medical Solutions and plans to introduce B2C products under the Avani brand in 2025. Vesisorb technology will be utilized for enhanced bioavailability.
Read the full story here
Written by: Steve Jones
Published on May 20, 2024 at 04:58PM
Source: Cannabiz (opens in new tab)